Woods Keith

COO Keith Woods sold 10,220 SRRK shares at $49.57; stock down 4.4% from 52-week high despite +7.1% 30-day rally.

Keith Woods, Chief Operating Officer of Scholar Rock, sold 10,220 shares (10.2K shares) at $49.57 on 2026-04-16 for $506.7K, reducing his holdings from 630.3K to 620.1K shares (-1.6%). The sale occurred near the 52-week high of $50.01 and substantially above the current price of $47.80, suggesting the transaction was executed at a favorable valuation window. Woods' prior sell at this ticker (on 2026-01-13) was followed by a +9.3% 30-day return and +16.0% 90-day return, indicating the stock moved higher after his last open-market sale — a poorly-timed outcome. The company's fundamentals remain concerning: the latest quarter showed $33.2M in revenue against a $-102.2M net loss, with full-year results also negative. This sell-side activity by the COO warrants observation given the company's unprofitability and the insider's prior misstep in timing.

COO Keith Woods sold 16,746 shares of SRRK at $42.70, reducing holdings to 583,254 shares as stock rises 5.0% in 30 days.

Keith Woods, Chief Operating Officer, sold 16,746 shares (16.7K shares) for $715,054.20 (715.1K), reducing his stake from 600,000 shares (600.0K shares) to 583,254 shares (583.3K shares) — a 2.8% reduction. The sale occurred at $42.70, below the current price of $46.53 and near the lower bound of the 52-week range ($24.47–$46.87). Scholar Rock is unprofitable with a full-year net income of $-102,220,000.00 ($-102.2M), though it achieved annual revenue growth of +76.4% to $33,193,000.00 ($33.2M) in the latest quarter. The stock has gained 5.0% over the past 30 days and 66.5% over the past 90 days, suggesting near recent-term strength. The sale represents a modest portfolio reduction by a senior executive from a late-stage unprofitable biotech company with strong top-line growth momentum.